AT - ALITA Therapeutics Email Formats

Biotechnology Research • • 1-10 Employees

Key Contact at AT - ALITA Therapeutics

Joshua J Heeley

CEO | Founder @ AT (ALITA Therapeutics Ltd)

Company overview

Headquarters	XX
Website	alita-therapeutics.com
NAICS	541714
Keywords	Cancer Immunotherapy, Oncology Therapeutics, Biotechnology R&D, Targeted Cancer Treatment, Smart Drug Design, Tumor-Selective Prodrugs
Founded	2025
Employees	1-10

About AT - ALITA Therapeutics

AT (ALITA Therapeutics) is pioneering smart cancer medicines designed to stay switched off in the body and only activate inside tumors. Our proprietary dual logic-gated co-prodrug platform responds to tumor proteases and hypoxia/ROS conditions, releasing a potent DNA-damaging payload only where it’s needed — while also stimulating local immune attack. This approach aims to maximize efficacy, minimize toxicity, and expand treatment options across some of the hardest-to-treat cancers.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Funding Data

AT - ALITA Therapeutics has never raised funding before.

Frequently asked questions

AT - ALITA Therapeutics is located in XX.

AT - ALITA Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

AT - ALITA Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at AT - ALITA Therapeutics

Joshua J Heeley

CEO | Founder @ AT (ALITA Therapeutics Ltd)

4.8

40,000 users